Lorenz Räber
Association of Preoperative Copeptin Levels with Risk of All-Cause Mortality in a Prospective Cohort of Adult Cardiac Surgery Patients.
Filipovic M, Huber M, Kobel B, Bello C, Levis A, Andereggen L, Kakizaki R, Stuber F, Räber L, Lüdi M. Association of Preoperative Copeptin Levels with Risk of All-Cause Mortality in a Prospective Cohort of Adult Cardiac Surgery Patients. Cells 2024; 13
15.07.2024Association of Preoperative Copeptin Levels with Risk of All-Cause Mortality in a Prospective Cohort of Adult Cardiac Surgery Patients.
15.07.2024Cells 2024; 13
Filipovic Mark G, Huber Markus, Kobel Béatrice, Bello Corina, Levis Anja, Andereggen Lukas, Kakizaki Ryota, Stuber Frank, Räber Lorenz, Lüdi Markus
Levels of Circulating Ketone Bodies in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass.
Levis A, Huber M, Mathis D, Filipovic M, Stieger A, Räber L, Stuber F, Lüdi M. Levels of Circulating Ketone Bodies in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass. Cells 2024; 13
06.02.2024Levels of Circulating Ketone Bodies in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass.
06.02.2024Cells 2024; 13
Levis Anja, Huber Markus, Mathis Déborah, Filipovic Mark G, Stieger Andrea, Räber Lorenz, Stuber Frank, Lüdi Markus
Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
Wagener M, Boeddinghaus J, Gaemperli O, Räber L, Nietlispach F, Meier P, Muller O, Weilenmann D, Jeger R. Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey. J Clin Med 2022; 11
15.12.2022Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
15.12.2022J Clin Med 2022; 11
Wagener Max, Boeddinghaus Jasper, Gaemperli Oliver, Räber Lorenz, Nietlispach Fabian, Meier Pascal, Muller Olivier, Weilenmann Daniel, Jeger Raban
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
Wenzl F, Kraler S, Ambler G, Weston C, Herzog S, Räber L, Muller O, Camici G, Roffi M, Rickli H, Fox K, de Belder M, Radovanovic D, Deanfield J, Lüscher T. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation. Lancet 2022; 400:744-756.
29.08.2022Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
29.08.2022Lancet 2022; 400:744-756
Wenzl Florian A, Kraler Simon, Ambler Gareth, Weston Clive, Herzog Sereina A, Räber Lorenz, Muller Olivier, Camici Giovanni G, Roffi Marco, Rickli Hans, Fox Keith A A, de Belder Mark, Radovanovic Dragana, Deanfield John, Lüscher Thomas F
Coronary and structural heart interventions in Switzerland 2019
Wagener M, Jeger R, Weilenmann D, Räber L, Nietlispach F, Muller O, Meier P, Gämperli O, Cook S, Twerenbold R, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology. Coronary and structural heart interventions in Switzerland 2019. Swiss Med Wkly 2021; 151:w20495.
11.05.2021Coronary and structural heart interventions in Switzerland 2019
11.05.2021Swiss Med Wkly 2021; 151:w20495
Wagener Max, Jeger Raban, Weilenmann Daniel, Räber Lorenz, Nietlispach Fabian, Muller Olivier, Meier Pascal, Gämperli Oliver, Cook Stéphane, Twerenbold Raphael, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial
Franzone A, Jüni P, Wenaweser P, Stortecky S, Räber L, Jamshidi P, Kaiser C, Weilenmann D, Cook S, Muller O, Vuilliomenet A, Tüller D, Roffi M, Heg D, Pilgrim T, Windecker S. Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial. Circ Cardiovasc Interv 2015; 8
01.06.2015Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial
01.06.2015Circ Cardiovasc Interv 2015; 8
Franzone Anna, Jüni Peter, Wenaweser Peter, Stortecky Stefan, Räber Lorenz, Jamshidi Peiman, Kaiser Christoph, Weilenmann Daniel, Cook Stéphane, Muller Olivier, Vuilliomenet André, Tüller David, Roffi Marco, Heg Dik, Pilgrim Thomas, Windecker Stephan